Investigating the risks of metal exposure from e-cigarette aerosol
Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol
This study is looking at how using e-cigarettes might expose younger users to harmful metals like nickel, chromium, and lead, and how these metals could be linked to brain diseases like Parkinson's, so we can better understand the health risks of vaping.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10878791 on NIH RePORTER |
What this research studies
This research focuses on understanding the health effects of chronic exposure to metal mixtures found in e-cigarette aerosol, particularly among younger users. The study aims to identify levels of neurotoxic metals, such as nickel, chromium, and lead, that may be released during e-cigarette use. By analyzing aerosol samples and comparing them to established safety standards, the researchers will explore the potential link between these metals and neurodegenerative diseases like Parkinson's. The findings could provide critical insights into the long-term health risks associated with e-cigarette use.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults who are regular e-cigarette users.
Not a fit: Patients who do not use e-cigarettes or are not exposed to e-cigarette aerosol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention of neurodegenerative diseases linked to e-cigarette use.
How similar studies have performed: Previous studies have indicated potential health risks associated with e-cigarette use, but this specific investigation into neurotoxic metals is relatively novel.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Re, Diane Berengere — Columbia University Health Sciences
- Study coordinator: Re, Diane Berengere
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.